Treatment of psoriatic arthritis has tended to follow evidence-based strategies for achieving remission or minimal disease activity in rheumatoid arthritis. However, distinct immunopathogenic ...

Individuals with self-reported moderate to severe psoriatic arthritis (PsA) face a higher disease burden, particularly among ...

In the phase 4 FOREMOST trial, treatment with apremilast improved both clinical and patient-reported outcomes at week 16 among patients with early oligoarticular PsA.

Psoriatic arthritis surgery could involve removing damaged tissue or bone or replacing a joint with severe damage. Learn more here.

Targeted therapies for PsA are effective for reducing the use of symptomatic treatments, sick leave, and rates of hospitalization.

The FDA today approved bimekizumab-bkzx (Bimzelx), an IL-17A and IL-17F inhibitor, for the treatment of adults with active psoriatic arthritis, those with active nonradiographic axial ...

Symptoms of psoriatic arthritis are similar to rheumatoid arthritis and include, pain, swelling and stiffness in one or more ...

Imuldosa is used for the treatment of patients with autoimmune diseases such as plaque psoriasis, psoriatic arthritis, ...

Psoriatic arthritis causes joint swelling and pain ... the condition is on your body How visible the condition is How much treatment is needed to manage your condition The VA uses all this ...

PRNewswire Ahmedabad Gujarat [India] October 14 Accord BioPharma Inc the US specialty division of Intas Pharmaceuticals Ltd ...

Biosimilars are safe, effective, and well-tolerated for psoriasis treatment, providing significant cost savings for the ...